-- Company poised to accelerate revenue growth into high single digits over next three years, enabled by core genomics portfolio -- Innovations to enable development of transformative applications using multiomics-- Illumina to offer higher quality insights to customers, helping them improve the overall end-to-end workflow experience and lower cost-- Delivering double digit to teens non-GAAP diluted earnings per share growth 2025-2027-- Illumina and the Broad Institute of MIT and Harvard announce new resear ...